RU
Address
220006, Minsk, Leningradskaya Str. 6, office 2
Tel.: +375 17 363-88-92
E-mail: medjournal@bsmu.by

Саркопения: этапы и причины возникновения, факторы риска

А. Т. Быков, Н. А. Корниенко, Т. Н. Маляренко КГМУ, РМУ
2015 №4 | Исторический ракурс
Аннотация
Список литературы
Скачать полнотекстовую статью
Саркопения характеризуется выраженным снижением массы, силы и функциональных возможностей скелетных мышц у старых людей, усугубляющим естественные процессы старения человека.
Ключевые слова:
Саркопения, пожилые люди
Sarcopenia: the stages and causes, risk factors

Sarcopenia is characterized by a pronounced decrease in mass, strength and functional capacity of skeletal muscle in older people, aggravating the natural processes of human aging.

Keywords
Sarcopenia, the elderly
  • 1. Быков, А. Т. Восстановительная медицина и экология человека. М.: ГЭОТАР-Медиа, 2009. 688 с.
  • 2. Aagaard, P., Suetta C., Caserotti P., et al. Role of the nervous system in sarcopenia and muscle atrophy with aging: strength training as a countermeasures // Scand. J. Sci. Sports. 2010. Vol. 20. P. 49–64.
  • 3. Batsis, J. A., Anker S. D., Barre L. K., et al. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutritional Examination Survey III // Europ. J. Clin. Nutr. 2014. Vol. 68, № 9. P. 1001–1007.
  • 4. Benton, M. J., Whyte M. D., Dyal B. W. Sarcopenic obesity: strategies for management Am. J. Nurs. 2011. Vol. 111. P. 38–44.
  • 5. Breen, L., Phillips S. M. Skeletal muscle protein metabolism in the elderly; interventions to counteract to ‘anabolic resistance’of ageing // Nutr. Metab. (Lond.). 2011. № 8. P. 68.
  • 6. Burton, L. A., Sumukadas D. Optimal management of sarcopenia // Clin. Interv. Aging. 2010. № 7. P. 217–228.
  • 7. Cooper, R. et al. R., Kuh D., Hardy R. Objectively measured physical capability levels and mortality systematic review and meta analysis // BVJ. 2010. Vol. 341. C. 4467.
  • 8. Cruz-Jentoft, A. J., Baeyens J. P., Bauer J. M. et al. Sarcopenia: European consensus on definition and diagnosis: Report of European Working Group on Sarcopenia in Older People // Age Ageing. 2010a. Vol. 39. P. 412–423.
  • 9. Cruz-Jentoft, A. J., Landi F., Schneider S. M. et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review // Report of the International Sarcopenia Initiative // Age Ageing. 2014. Vol. 43, № 6. P. 748–759.
  • 10. Cruz-Jentoft, A. J., Landi F., Topinkovq F., Michel J. P. Understanding sarcopenia as a geriatric syndrome // Curr. Opin. Clin. Nutr. Metab. Care. 2010c. Vol. 13. P. 1–7.
  • 11. Denison, H. J., Cooper C., Sayer A., Robinson S. M. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people // Clin. Intervent. In Aging. 2015. Vol. 10, № 559–569.
  • 12. Fielding, R. A., Vellas B., Evans W. J., et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. Internationak working group on sarcopenia // J. Am. Med. Dir. Assoc. 2011. Vol. 12. P. 249–256.
  • 13. Iolascon, G., Pietro G., Gimigliano G. et al. Physical exercise and sarcopenia in older people: position paper of the Italian Society of Orthopaedia and Medicine (OrtoMed) // Clin. Cases Miner Bone Metab. 2014 Sep. Vol. 11, №3. P. 215–221.
  • 14. Jahn, K., Heinze C., Selge C., Schniero R. Gait disorders in geriatric patients. Classification and therapy // Nervenartz. 2015 Apr. Vol. 86, №4. P. 431–439.
  • 15. Janssen, I., Shepard D. S., Katzmarzyk P. T., Roubenoff R. The healthcare costs of sarcopenia in the United States // J. Am. Geriatr. Sci. 2005. Vol. 52. P. 80–85.
  • 16. Khor, S. C., Abdul Karim N., Wan Ngah W. Z., et al. Vitamin E in sarcopenia: current evidences on its role in prevention and treatment // Oxidative Medicine and Cellular Longevity. 2014. Vol. 2014. ID 914853. 16 p.
  • 17. Kim, J. S., Wilson J. M., Lee S. R. Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants // J. Nutr. Biochem. 2010. Vol. 21. P. 1–13.
  • 18. Loenneke, J. P., Pujol T. J. Sarcopenia: an emphasis on occlusion training and dietary protein // Hippokratia. 2011. Vol. 15. P. 132–137.
  • 19. Mathers, J. C. Impact of nutrition on the ageing process // Br. J. Nut. 2015. Vol. 113 Suppl. S18-S22.
  • 20. Millward, D. J. Nutrition and sarcopenia: evidence for an interaction // Proc. Nutr. Soc. 2012. Vol. 71, № 4P. 566–575.
  • 21. Montero-Fernandez, N. I., Serra-Rexach J. A. Role of exercise on sarcopenia in the elderly // Europ. J. Phys. Rehabil. Med. 2013. Vol. 49, № 1. P. 131–143.
  • 22. Morley, J. E., Anker S. D., von Haehling S. Prevalence, incidence and clinical impact of sarcopenia: facts, numbers, and epidemiologyupdate 2014 // J. Cachexia Sarcopenia Muscle. 2014. Vol. 5, № 4.P. 253–259.
  • 23. Nicastro, H., Artioli G. G., Costa Ados S., et al., An overview of the therapeutic effects of leucine supplemention on skeletal muscle under atrophic conditions // Amino Acids. 2011. 2011. Vol. 40.P. 287–300.
  • 24. Patel, H. P., Seddall H. E., Jameson K., et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWSKOP) definition: finding from the Hertfordshire Cohort Study (HCS) // Age Ageing. 2013. Vol. 42, № 3. P. 378–384.
  • 25. Rom, O., Kaisari Sh., Aizenbud D., Resnick A. Z. Identification of possible cigarette smoke constituents responsible for muscular catabolism // J. Muscle Res. Motil. 2012a. Vol. 33. P. 199–208.
  • 26. Rom, O., Kaisari Sh., Aizenbud D., Resnick A. Z. Lifestyle and sarcopenia – etiology, prevention and treatment // Rambam Maimonides Medical J. 2012 b. Vol. 3, Issue 4. e0024. (12 p.).
  • 27. Rom, O., Kaisari Sh., Aizenbud D., Resnick A. Z. Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown // Ann. NY Acad Sci. 2012c. Vol. 1259. P. 47–53.
  • 28. Rosenberg, I. H. Sarcopenia: origins and clinical relevance // J. Nutr. 1997. Vol. 127. P. 990- 1001.
  • 29. Sayer, A. A. Sarcopenia: a new geriatric giant: time to translate research finding into clinical practice // Age Ageing. 2014. Vol. 43, № 6. P. 736–737.
  • 30. Sayer, A. A., Robinson S. M., Patel H. P. et al. New horizons in the pathogenesis, diagnosis and management of sarcopenia // Age Ageing. 2013. Vol. 43, № 2. P. 145–150.
  • 31. Sharples, A. P., Hughes D. C., Deane C. S. et al. Longevity and skeletal muscle mass: the role of IGF signaling, the sirtuins, dietary restriction and protein intake // Aging Cell. 2015. Vol. 14 P. 511–523.
  • 32. Symons, T. B., Schultzler S. E., Cocke T. L., et al. Aging does not impair the anabolic response to protein-rich meal // Am. J. Clin. Nutr. 2007. Vol. 86. P. 451–456.
  • 33. Tan, L. J., Liu S. L., Lei S. F. et al. Molecular genetic studies of gene identification for sarcopenia // Hum. Genet. 2012. Vol. 131. P. 1–31.
  • 34. Tohma, H., Hepworth A. R., Shavlakadze T. et al. Quantification of ceroid and lipofuscin in skeletal muscle // J. Histochem. Cytochem. 2011. Vol. 59. P. 769–779.
  • 35. Visvanathan, R., Chapman I. Preventing sarcopenia in older people // Maturitas. 2010. Vol. 66. P. 383–388.
  • 36. Waters, D. L., Baumgartner R. N., Garry P. J., Vellas B.Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients; an update // Clin. Interv. Aging. 2010. № 7. P. 259–270.